Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Studying the Effects of Sibutramine on Eating Behavior.

Next Previous
Trial Profile

Studying the Effects of Sibutramine on Eating Behavior.

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 14 Jan 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sibutramine (Primary)
  • Indications Obesity
  • Focus Therapeutic Use

Most Recent Events

  • 27 Feb 2012 Actual end date 1 Oct 2010 added as reported by ClinicalTrials.gov.
  • 27 Feb 2012 Actual initiation date Feb 2009 and patient number 17 added as reported by ClinicalTrials.gov.
  • 27 Feb 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top